{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:12:40Z","timestamp":1792033960324,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["653316"],"award-info":[{"award-number":["653316"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-20- 11CE-0024-02"],"award-info":[{"award-number":["ANR-20- 11CE-0024-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109104","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:53:26Z","timestamp":1760500406000},"page":"109104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis and in vitro inhibitory activity of N-arylsulfonamide adenosine analogues designed to target SARS-CoV-2 nsp14 N7-methyltransferase"],"prefix":"10.1016","volume":"166","author":[{"given":"Marcel","family":"Hausdorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Delpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Machin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Zoladek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Gucciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendriya","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Muriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Nisole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Debart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109104_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115719","article-title":"A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19","volume":"260","author":"Kushwaha","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/v16050757","article-title":"COVID-19 variants and vaccine development","volume":"16","author":"Zhao","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2025.109104_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130110","article-title":"Nucleoside antiviral agents with atypical structures and new targets","volume":"119","author":"Xu","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109104_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109104_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109104_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105514","article-title":"Targeting SARS-CoV-2 and host cell receptor interactions","volume":"210","author":"Lim","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2025.109104_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115745","article-title":"Druggable targets from coronaviruses for designing new antiviral drugs","volume":"28","author":"Silva","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103832","article-title":"Targeting SARS-CoV-2 nonstructural protein 3: function, structure, inhibition, and perspective in drug discovery","volume":"29","author":"Li","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109104_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115772","article-title":"Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review","volume":"260","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.26264","article-title":"RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bioorg.2025.109104_bb0055","doi-asserted-by":"crossref","first-page":"18642","DOI":"10.1021\/acs.jmedchem.4c01749","article-title":"Perspective for drug discovery targeting SARS coronavirus methyltransferases: function, structure and inhibition","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/v14020379","article-title":"Targeting viral methyltransferases: an approach to antiviral treatment for ssRNA viruses","volume":"14","author":"Ramdhan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2025.109104_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108709118","article-title":"Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication","volume":"118","author":"Ogando","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.109104_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2533\/chimia.2022.409","article-title":"Comparison of the old and new - novel mechanisms of action for anti-coronavirus nucleoside analogues","volume":"76","author":"Thames","year":"2022","journal-title":"Chimia"},{"key":"10.1016\/j.bioorg.2025.109104_bb0075","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0080","doi-asserted-by":"crossref","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109104_bb0085","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109104_bb0090","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1021\/acs.jmedchem.4c02561","article-title":"Discovery of Nirmatrelvir (PF-07321332): a potent, orally active inhibitor of the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Main protease","volume":"68","author":"Tuttle","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0095","doi-asserted-by":"crossref","first-page":"eade8778","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2025.109104_bb0100","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 Main protease confer drug resistance to Nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2025.109104_bb0105","doi-asserted-by":"crossref","first-page":"eabo0718","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109104_bb0110","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1093\/nar\/gkac224","article-title":"Chemical biology and medicinal chemistry of RNA methyltransferases","volume":"50","author":"Fischer","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109104_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/nar\/gkab1279","article-title":"Coronaviral RNA-methyltransferases: function, structure and inhibition","volume":"50","author":"Nencka","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109104_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coviro.2017.04.003","article-title":"Biochemical principles and inhibitors to interfere with viral capping pathways","volume":"24","author":"Decroly","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bioorg.2025.109104_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115713","article-title":"Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro","volume":"28","author":"Thames","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112557","article-title":"Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase","volume":"201","author":"Ahmed-Belkacem","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0135","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1042\/BCJ20210219","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14 RNA cap methyltransferase","volume":"478","author":"Basu","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.109104_bb0140","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsmedchemlett.1c00140","article-title":"Potent SARS-CoV-2 mRNA cap methyltransferase inhibitors by bioisosteric replacement of methionine in SAM cosubstrate","volume":"12","author":"Bobileva","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109104_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121243","article-title":"Discovery of SARS-CoV-2 nsp14 and nsp16 methyltransferase inhibitors by high-throughput virtual screening","volume":"14","author":"Bobrovs","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109104_bb0150","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/24725552211026261","article-title":"Probing the SAM binding site of SARS-CoV-2 nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors","volume":"26","author":"Devkota","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.bioorg.2025.109104_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105142","article-title":"Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-methyltransferase","volume":"193","author":"Kasprzyk","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2025.109104_bb0160","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","article-title":"The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors","volume":"7","author":"Otava","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109104_bb0165","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1021\/acs.jmedchem.2c00120","article-title":"Potent inhibition of SARS-CoV-2 nsp14 N7-methyltransferase by sulfonamide-based bisubstrate analogues","volume":"65","author":"Ahmed-Belkacem","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0170","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acsmedchemlett.2c00265","article-title":"Bisubstrate inhibitors of severe acute respiratory syndrome coronavirus-2 nsp14 methyltransferase","volume":"13","author":"Jung","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109104_bb0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/molecules28020768","article-title":"3-(Adenosylthio)benzoic acid derivatives as SARS-CoV-2 Nsp14 methyltransferase inhibitors","volume":"28","author":"Bobileva","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109104_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115474","article-title":"Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases","volume":"256","author":"Hausdorff","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0185","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.2c02120","article-title":"Structure-based discovery of inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase","volume":"66","author":"Singh","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0190","doi-asserted-by":"crossref","first-page":"27410","DOI":"10.1021\/acsomega.3c02815","article-title":"Rational Design of Highly Potent SARS-CoV-2 nsp14 methyltransferase inhibitors","volume":"8","author":"\u0160tefek","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109104_bb0195","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1039\/D4MD00422A","article-title":"Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5\u2032-carboxamides","volume":"15","author":"Kocek","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107894","article-title":"Identification of adenosine analogues as nsp14 N7-methyltransferase inhibitors for treating coronaviruses infection","volume":"153","author":"Chen","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0205","article-title":"The quinazoline-2,4(1H,3H)-diones skeleton: a key intermediate in drug synthesis","volume":"27","author":"Gheidari","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.bioorg.2025.109104_bb0210","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/acs.jmedchem.5b01157","article-title":"C-nucleosides to be revisited","volume":"59","author":"De Clercq","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cmdc.201700657","article-title":"Synthesis and biological evaluation of Pyrrolo[2,1-f][1,2,4]triazine C-nucleosides with a ribose, 2\u2032-deoxyribose, and 2\u2032,3\u2032-Dideoxyribose sugar moiety","volume":"13","author":"Li","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109104_bb0220","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/acs.oprd.0c00310","article-title":"Improvement of the C-glycosylation step for the synthesis of remdesivir","volume":"24","author":"Xue","year":"2020","journal-title":"Org. Process. Res. Dev."},{"key":"10.1016\/j.bioorg.2025.109104_bb0225","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.bmc.2017.07.063","article-title":"Synthesis and evaluation of analogs of 5\u2032-(((Z)-4-amino-2-butenyl)methylamino)-5\u2032-deoxyadenosine (MDL 73811, or AbeAdo) \u2013 an inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity","volume":"25","author":"Brockway","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109104_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/ph18030297","article-title":"Prodrug approach as a strategy to enhance drug permeability","volume":"18","author":"de Souza","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109104_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618756430","article-title":"Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection","volume":"26","author":"Dousson","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bioorg.2025.109104_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109104_bb0250","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/jm5017279","article-title":"Discovery of 4\u2032-Chloromethyl-2\u2032-deoxy-3\u2032,5\u2032-di-O-isobutyryl-2\u2032-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0255","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3891\/acta.chem.scand.50-0609","article-title":"Ether, carbonate and urethane Deoxynucleoside derivatives as prodrugs","volume":"50","author":"Hammer","year":"1996","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.bioorg.2025.109104_bb0260","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/jm0701021","article-title":"Liver-targeted prodrugs of 2\u2018-C-Methyladenosine for therapy of hepatitis C virus infection","volume":"50","author":"Hecker","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0265","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/cmdc.201500381","article-title":"pH-cleavable nucleoside lipids: a new paradigm for controlling the stability of lipid-based delivery systems","volume":"10","author":"Oumzil","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109104_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkl1119","article-title":"High-yield production of short GpppA- and 7MeGpppA-capped RNAs and HPLC-monitoring of methyltransfer reactions at the guanine-N7 and adenosine-2'O positions","volume":"35","author":"Peyrane","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109104_bb0275","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0280","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/jm00020a007","article-title":"Mononucleoside Phosphotriester derivatives with S-Acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3\u2032-Azido-2\u2032,3\u2032-dideoxythymidine 5'-monophosphate","volume":"38","author":"Lefebvre","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0285","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/jm9507338","article-title":"Decomposition pathways and in vitro HIV inhibitory effects of IsoddA Pronucleotides: toward a rational approach for intracellular delivery of nucleoside 5\u2018-monophosphates","volume":"39","author":"Valette","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0295","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109104_bb0300","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple Ligand\u2013Protein Interaction Diagrams for Drug Discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:43:50Z","timestamp":1773301430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"alternative-id":["S0045206825009848"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109104","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro inhibitory activity of N-arylsulfonamide adenosine analogues designed to target SARS-CoV-2 nsp14 N7-methyltransferase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109104"}}